Lack of early diagnosis makes neurodegeneration (NDG) the 7th deadliest disease in the world. Use the following platform to identify potential disease triggers and get access to targeted drug development:
Clinical-data-calibrated neuro In finite platform predicting NDG in human patients based on early in vitro events
Class of novel IATA NAM test method
application
Application 1 – by pharmaceutical companies…
…developing drugs for NDG diseases, particularly Alzheimer’s. Our model can simulate years of environmentally triggered disease development without genetic manipulations, representing 99% of Alzheimer’s cases.
Application 2 – by chemical & material industry…
…for workforce protection by predicting the neurotoxicity of existing and novel materials and chemicals.